180 related articles for article (PubMed ID: 6335020)
1. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
Maudgal PC; De Clercq E; Missotten L
Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
[TBL] [Abstract][Full Text] [Related]
2. Topical BVDU plus low-dosage steroids in the treatment of chronic relapsing zoster keratouveitis. A pilot study.
Ameye C; Sundmacher R; de Clercq E
Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):118-22. PubMed ID: 2656415
[TBL] [Abstract][Full Text] [Related]
3. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the topical treatment of herpes simplex keratitis.
Maudgal PC; Missotten L; De Clercq E; Descamps J; De Meuter E
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):261-8. PubMed ID: 7020469
[TBL] [Abstract][Full Text] [Related]
5. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E
Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
[TBL] [Abstract][Full Text] [Related]
7. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
Maudgal PC; De Clercq E; Descamps J; Missotten L
Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
[No Abstract] [Full Text] [Related]
9. Experimental thymidine kinase-deficient HSV-1 keratitis: therapeutic attempts.
Maudgal PC; De Clercq E; Huyghe P
Curr Eye Res; 1987 Apr; 6(4):579-84. PubMed ID: 2953558
[TBL] [Abstract][Full Text] [Related]
10. Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: a preliminary clinical trial.
Tricot G; De Clercq E; Boogaerts MA; Verwilghen RL
J Med Virol; 1986 Jan; 18(1):11-20. PubMed ID: 3511181
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
[TBL] [Abstract][Full Text] [Related]
12. Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():193-9. PubMed ID: 1650667
[TBL] [Abstract][Full Text] [Related]
13. Viral keratitis.
McGill J; Scott GM
Br Med Bull; 1985 Oct; 41(4):351-6. PubMed ID: 2413949
[No Abstract] [Full Text] [Related]
14. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
de Clercq E; Zhang ZX; Sim IS
Antimicrob Agents Chemother; 1982 Sep; 22(3):421-5. PubMed ID: 7137983
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
Rajcáni J; Reefschläger J
Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
[TBL] [Abstract][Full Text] [Related]
17. Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
de Clercq E
Antimicrob Agents Chemother; 1984 Aug; 26(2):155-9. PubMed ID: 6486759
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic efficacy of E-5-(2-bromovinyl)-2'deoxyuridine for orofacial infection with herpes simplex virus type 1 in mice.
Park NH; Pavan-Langston D; Boisjoly HM; De Clercq E
J Infect Dis; 1982 Jun; 145(6):909-13. PubMed ID: 6979592
[TBL] [Abstract][Full Text] [Related]
19. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
Freeman DJ; Sacks SL; De Clercq E; Spruance SL
Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the treatment of experimental herpes simplex virus encephalitis in mice.
Park NH; Pavan-Langston D; de Clercq E
Antiviral Res; 1983 Mar; 3(1):7-15. PubMed ID: 6870230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
